Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$820M |
| 2 |
Palo Alto Networks
PANW
|
+$358M |
| 3 |
Visa
V
|
+$355M |
| 4 |
CELG
Celgene Corp
CELG
|
+$339M |
| 5 |
Citigroup
C
|
+$325M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$722M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$356M |
| 3 |
Alibaba
BABA
|
+$345M |
| 4 |
EOG Resources
EOG
|
+$344M |
| 5 |
Canadian Pacific Kansas City
CP
|
+$321M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.08% |
| 2 | Consumer Discretionary | 17.25% |
| 3 | Communication Services | 14.3% |
| 4 | Technology | 13.13% |
| 5 | Financials | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AGN.PRA
526
DELISTED
Allergan plc
AGN.PRA
| $7.08M | 0.01% |
7,500
| – | – |
|
|
ALPN
527
DELISTED
Alpine Immune Sciences Inc
ALPN
| $7.07M | 0.01% |
137,887
-6,409
| -4% | -$421K |
|
|
BPL
528
DELISTED
Buckeye Partners, L.P.
BPL
| $6.98M | 0.01% |
117,842
+52,724
| +81% | +$3.66M |
|
|
TEP
529
DELISTED
Tallgrass Energy Partners, LP
TEP
| $6.8M | 0.01% |
173,049
+36,212
| +26% | +$1.63M |
|
|
GNMX
530
DELISTED
Aevi Genomic Medicine Inc
GNMX
| $6.58M | 0.01% |
841,959
+165,089
| +24% | +$1.28M |
|
|
CNCE
531
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $6.33M | 0.01% |
337,193
+2,507
| +0.7% | +$42.6K |
|
|
CSII
532
DELISTED
Cardiovascular Systems, Inc.
CSII
| $5.98M | 0.01% |
377,752
-95,079
| -20% | -$2.4M |
|
|
ADAP
533
DELISTED
Adaptimmune Therapeutics
ADAP
| $5.81M | 0.01% |
485,401
+135,401
| +39% | +$1.91M |
|
|
PRTK
534
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $5.76M | 0.01% |
303,048
+1,534
| +0.5% | +$38.2K |
|
535
MacroGenics
MGNX
$240M
| $5.71M | 0.01% |
266,499
+176,443
| +196% | +$5.53M |
|
|
RLYP
536
DELISTED
RELYPSA INC COM
RLYP
| $5.62M | 0.01% |
303,767
+1,567
| +0.5% | +$43.1K |
|
537
FerroAtlántica
GSM
$600M
| $5.58M | 0.01% |
460,311
-42,107
| -8% | -$622K |
|
538
Plains All American Pipeline
PAA
$17.5B
| $5.53M | 0.01% |
182,001
+145,008
| +392% | +$5.3M |
|
539
Douglas Emmett
DEI
$2.02B
| $5.51M | 0.01% |
191,768
-241,565
| -56% | -$7M |
|
|
DSCI
540
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $5.4M | 0.01% |
1,145,688
+5,242
| +0.5% | +$33.8K |
|
|
AIMT
541
DELISTED
Aimmune Therapeutics
AIMT
| $5.08M | 0.01% |
+200,503
| New | +$4.69M |
|
542
Sarepta Therapeutics
SRPT
$1.64B
| $4.78M | ﹤0.01% |
148,798
-204,202
| -58% | -$6.93M |
|
|
HIFR
543
DELISTED
InfraREIT, Inc.
HIFR
| $4.6M | ﹤0.01% |
+194,373
| New | +$5.69M |
|
|
NS
544
DELISTED
NuStar Energy L.P.
NS
| $4.53M | ﹤0.01% |
100,993
+31,307
| +45% | +$1.65M |
|
545
Century Aluminum
CENX
$4.44B
| $4.44M | ﹤0.01% |
964,870
+12,585
| +1% | +$87.8K |
|
|
EEP
546
DELISTED
Enbridge Energy Partners
EEP
| $4.44M | ﹤0.01% |
179,528
+49,211
| +38% | +$1.41M |
|
547
SCYNEXIS
SCYX
$37M
| $4.36M | ﹤0.01% |
7,480
+24
| +0.3% | +$14.7K |
|
|
TRNX
548
DELISTED
TORNIER N V SHARES (NLD)
TRNX
| $4.27M | ﹤0.01% |
209,405
+1,636
| +0.8% | +$39.3K |
|
549
Brookfield Infrastructure Partners
BIP
$19.5B
| $4.18M | ﹤0.01% |
+286,605
| New | +$4.63M |
|
|
OKS
550
DELISTED
Oneok Partners LP
OKS
| $4.13M | ﹤0.01% |
+141,199
| New | +$4.57M |
|
Similar funds
Jennison Associates's Q3 2015 Portfolio in Review
As of Q3 2015, Jennison Associates held 813 positions worth $97.6B, down 11% from $109B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Jennison Associates's Q3 2015 filing shows 84 new, 272 increased, 353 reduced and 92 closed positions. Its largest new stake was Palo Alto Networks: 12,124,434 shares worth $348M. The largest sale was Gilead Sciences, an estimated $722M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, down from 21% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Jennison Associates's largest Q3 2015 buy was Palo Alto Networks: 12,124,434 shares worth $348M.
- Jennison Associates added most to Alphabet (Google) Class C in Q3 2015, an estimated $820M increase.
- Jennison Associates's biggest Q3 2015 reduction was Gilead Sciences, cutting an estimated $722M.
- Jennison Associates fully exited KRAFT FOODS GROUP INC COM STK (VA) in Q3 2015, selling an estimated $144M.
- Jennison Associates's ten largest holdings make up 24% of its $97.6B portfolio in Q3 2015.
- Jennison Associates opened 84 new positions and closed 92 in Q3 2015.
- Jennison Associates's portfolio value fell 11% quarter-over-quarter to $97.6B.
Based on Jennison Associates's 13F filing for Q3 2015, filed 6 Nov 2015.